AI Modernization Pipeline Will Shape Banking Exposure And Margin Stability

Catalysts

About Mphasis

Mphasis is an IT services company that provides application, infrastructure and AI led solutions to global clients, with a large presence in banking, financial services and insurance.

What are the underlying business or industry changes driving this perspective?

• Although client interest in AI led modernization is high, with NeoIP linked customers already accounting for more than 50% of company revenue, the shift from pilots to large scale programs may be uneven across accounts. This can temper how quickly the current US$2.1b LTM TCV converts into higher revenue and earnings.
• While the AI focused deal pipeline is growing, with 69% of pipeline described as AI led, many of these contracts involve complex transformation and fixed price constructs. Any delivery slippage or scope creep could put pressure on net margins even if headline TCV and revenue remain healthy.
• Although banking and insurance now contribute about 66% of revenue and are seeing strong AI and modernization demand, this concentration leaves Mphasis exposed to any slowdown or reprioritization of tech budgets in financial services. This could affect future revenue growth and earnings stability.
• While AI agents and AIOps can reduce human effort and potentially support higher margin work over time, management is currently recycling much of the efficiency into NeoIP platform and ecosystem investments. This may cap near term EBIT margin within the 14.75% to 15.75% band despite higher revenue from large deals.
• Although cloud and hyperscaler aligned offerings, along with AI orchestration across the IT value chain, are expanding the addressable market and have lifted the large deal pipeline to a very large multiple of past levels, the need to share value with clients and partners could limit pricing power and slow improvement in net margins and earnings per share.

Assumptions

How have these above catalysts been quantified?

• This narrative explores a more pessimistic perspective on Mphasis compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
• The bearish analysts are assuming Mphasis's revenue will grow by 10.0% annually over the next 3 years.
• The bearish analysts assume that profit margins will increase from 11.7% today to 12.4% in 3 years time.
• The bearish analysts expect earnings to reach ₹25.3 billion (and earnings per share of ₹132.1) by about March 2029, up from ₹18.0 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as ₹29.4 billion.
• In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 25.7x on those 2029 earnings, up from 22.0x today. This future PE is greater than the current PE for the IN IT industry at 20.2x.
• The bearish analysts expect the number of shares outstanding to grow by 0.25% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 16.06%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

• The rapid build out of the NeoIP AI platform, which management describes as creating one of the most exciting growth opportunities of this generation and already linked to more than 50% of revenue, could lead to stronger than expected client adoption and larger deal sizes. This would support faster growth in revenue and earnings than implied by a flat share price view.
• The long term trend toward AI led modernization across banks and insurers, with BFSI already contributing 66% of revenue and showing strong demand for AI and modernization, may continue to support wallet share gains and sustained deal momentum. This could push revenue and earnings higher than a scenario where the share price stays around current levels.
• If AI agents and AIOps keep reducing human effort in delivery and Mphasis eventually captures more of that efficiency in its own P&L rather than recycling most of it into platform investment, EBIT margin could move above the current 14.75% to 15.75% band. This would be inconsistent with an assumption that the share price remains broadly unchanged given higher profitability and earnings.
• The company reports record AI led pipeline, record large deal pipeline and LTM TCV of US$2.1b, with management describing steady TCV to revenue conversion. If this correlation between TCV and revenue strengthens further, the resulting uplift in revenue and earnings could challenge the belief that the share price will stay roughly flat.
• Management comments that client tech budgets are expected to be stable to slightly up, with spend shifting towards AI stack build out rather than shrinking overall. If Mphasis continues to position itself on the side of this spend that is growing, the long term effect on revenue growth, net margins and earnings could be stronger than a scenario where the share price does not move much.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bearish price target for Mphasis is ₹2164.64, which represents up to two standard deviations below the consensus price target of ₹2973.49. This valuation is based on what can be assumed as the expectations of Mphasis's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ₹3520.0, and the most bearish reporting a price target of just ₹2140.0.
• In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be ₹204.4 billion, earnings will come to ₹25.3 billion, and it would be trading on a PE ratio of 25.7x, assuming you use a discount rate of 16.1%.
• Given the current share price of ₹2073.8, the analyst price target of ₹2164.64 is 4.2% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.